FDA grants first-ever marketing authorization for ZYN nicotine pouches following a scientific review that showed lower health risks compared to traditional tobacco products and minimal youth usage.
Mineralys Therapeutics receives FDA clearance for a phase II clinical trial investigating lorundrostat, an aldosterone synthase inhibitor, in patients with moderate-to-severe obstructive sleep apnea and hypertension.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
The U.S. Justice Department's report reveals violations of federal law in the involuntary commitment of individuals with mental illness and substance abuse disorders to psychiatric hospitals in Oklahoma, as well as mishandling of mental health crises by the police.